Rockwell Medical, Inc.
As of Oct 22, 2026, Rockwell Medical is in Stage 1, the basing phase, now in week 9 (since Aug 25, 2026). It closed at $7.06, 44.0% below its 52-week high and below its 200-day average, which is falling.
Rockwell Medical, Inc., together with its subsidiaries, engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. More about the company
Pro read
ProOur read
Setup score
Momentum
Edge
Is RMTI early, or has it already run? Pro answers that for every US stock we cover, after every close.
Renews monthly until you cancel. Cancel any time in Plan & billing.
RMTI among Drug Manufacturers - Specialty & Generic52nd of 84 by relative strength
All 84 →| # | Stock | Stage | RS | 1M |
|---|---|---|---|---|
| 1 | CPIX | Stage 2 · wk 23 | 98 | +6.8% |
| 2 | ETON | Stage 2 · wk 30 | 97 | −10.1% |
| 3 | ANIK | Stage 2 · wk 15 | 96 | +3.5% |
| 4 | IRWD | Stage 3 · wk 3 | 96 | −16.4% |
| 5 | TEVA | Stage 2 · wk 9 | 95 | +3.1% |
| 6 | AMRX | Stage 2 · wk 19 | 95 | +5.9% |
| 7 | KNSA | Stage 2 · wk 73 | 95 | +6.2% |
| 8 | AMLX | Stage 2 · wk 15 | 93 | −6.6% |
| …52 | RMTI | Stage 1 · wk 9 | 28 | −17.6% |
Rockwell Medical: quick answers
What stage is Rockwell Medical in?
As of Oct 22, 2026, Rockwell Medical (RMTI) is in Stage 1, the basing phase. It entered Stage 1 on Aug 25, 2026 and is in week 9. What the four stages mean
Is Rockwell Medical in an uptrend?
Not yet. Rockwell Medical is in Stage 1, a base that can come before an uptrend. It trades 15.1% below its 200-day average, which is falling.
How far is Rockwell Medical from its 52-week high?
Rockwell Medical closed at $7.06 on Oct 22, 2026, 44.0% below its 52-week high of $12.60. Its 52-week low is $5.19.
How has Rockwell Medical performed over the past year?
As of Oct 22, 2026, Rockwell Medical is down 40.2% over the past year and down 17.9% so far in 2026.
Which sector and industry is Rockwell Medical in?
Rockwell Medical is in the Drug Manufacturers - Specialty & Generic industry, part of the Health Care sector.
About this companyHealth Care· Drug Manufacturers - Specialty & Generic
Rockwell Medical, Inc., together with its subsidiaries, engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. It offers citrapure citric acid concentrate, dri-sate dry acid concentrate, renalpure liquid acid concentrate, dri-sate acid concentrate mixer, renalpure acid concentrate, renalpure bicarbonate concentrate, sterilyte bicarbonate concentrate, bicarbonate cartridges, and dry acid concentrate mixer, as well as ancillary products, including 5% acetic acid, cleaner, citric acid descaler, water softener salt pellets, and other supplies used by hemodialysis providers. The company's hemodialysis concentrate products are used to sustain patient's life by removing toxins and balancing electrolytes in a dialysis patient's bloodstream. In addition, it offers dialysis concentrates, dialysis kits, and other ancillary products used in the dialysis process. The company was formerly known as Rockwell Medical Technologies, Inc. and changed its name to Rockwell Medical, Inc. in June 2012. Rockwell Medical, Inc. was incorporated in 1996 and is headquartered in Wixom, Michigan.
Visit company website →All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.